Skip to main content

Psoriasis clinical trials at UC Davis

1 research study open to eligible people

Showing trials for
  • Study of NDI-034858 in People With Moderate to Severe Plaque Psoriasis

    “Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”

    open to eligible people ages 18-70

    This is a Phase 2b, randomized, multicenter, double-blind, placebo-controlled, multiple-dose study designed to evaluate the efficacy, safety, and tolerability of NDI-034858 in subjects with moderate to severe plaque psoriasis. This study will also evaluate the plasma concentrations of NDI-034858 and explore the immune response to NDI-034858 in subjects with moderate to severe plaque psoriasis.

    Sacramento, California and other locations

Last updated: